REPROCELL U.S.A., INC.

REPROCELL U.S.A., INC. specializes in advanced molecular diagnostics and laboratory services focused on human and model organism sample processing. The company delivers high-precision RNA and DNA extraction from complex biological matrices, including whole blood, mouse tissues, and human clinical samples, supporting genomic research and translational science initiatives. Their technical expertise lies in maintaining sample integrity for downstream applications such as next-generation sequencing, transcriptomics, and biomarker discovery, with demonstrated proficiency in clinical-grade cell line development and in-vitro diagnostic substance manufacturing. A key differentiator is their ability to produce reproducible, research-ready biological materials under controlled conditions, ensuring consistency for sensitive genomic assays and preclinical studies. The contractor has established a consistent relationship with the Department of Health and Human Services, providing critical laboratory services for genomic research programs, including those under the National Human Genome Research Institute. They also support the Department of Veterans Affairs with specialized diagnostic reagents and clinical-grade seed clones, indicating a focus on precision medicine and veteran-specific biomedical research initiatives. These engagements reflect a pattern of serving agencies engaged in long-term, high-compliance biomedical research requiring traceable, validated biological materials. REPROCELL U.S.A., INC. operates primarily under NAICS 541380 for testing laboratories and 325413 for in-vitro diagnostic substance manufacturing, positioning them at the intersection of research support and regulated diagnostic production. Their market focus is on life sciences research, particularly in genomics and personalized medicine, serving government-funded programs that require GMP-like rigor in non-clinical settings. They are not certified under federal small business or socio-economic programs, and their presence is centered in Beltsville, Maryland, leveraging proximity to federal research hubs and biotech infrastructure to serve national health and science missions.